Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Vycor Medical (VYCO) Dividends payables (2023 - 2025)

Vycor Medical has reported Dividends payables over the past 3 years, most recently at $2.9 million for Q4 2025.

  • Quarterly Dividends payables rose 12.5% to $2.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.9 million through Dec 2025, up 12.5% year-over-year, with the annual reading at $2.9 million for FY2025, 12.5% up from the prior year.
  • Dividends payables was $2.9 million for Q4 2025 at Vycor Medical, roughly flat from $2.9 million in the prior quarter.
  • Over five years, Dividends payables peaked at $2.9 million in Q3 2025 and troughed at $2.3 million in Q4 2023.
  • The 3-year median for Dividends payables is $2.6 million (2024), against an average of $2.6 million.
  • Year-over-year, Dividends payables grew 14.29% in 2024 and then grew 12.5% in 2025.
  • A 3-year view of Dividends payables shows it stood at $2.3 million in 2023, then grew by 14.29% to $2.6 million in 2024, then grew by 12.5% to $2.9 million in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Dividends payables are $2.9 million (Q4 2025), $2.9 million (Q3 2025), and $2.8 million (Q2 2025).